LAMP

Mar 17, 2022

Anavasi Diagnostics Poised to Debut Rapid POC MDx System, COVID-19 Test
Premium

Feb 8, 2022

Lucira Health Enters Debt Facility of up to $80M

Feb 3, 2022

UK Researchers Develop Low-Cost Molecular COVID-19 Testing in a Backpack
Premium

Feb 1, 2022

Cheap, Rapid 'Flurona' Test Developed by UCSB Solves Problems With LAMP Sensitivity
Premium

Jan 18, 2022

Canary Molecular POC SARS-CoV-2 Test Nabs CE Mark

Jan 13, 2022

UIC Researchers Using Optimized RT-Lamp Technology for Low-Cost COVID-19 Testing
Premium

Dec 8, 2021

Genedrive Rapid Molecular COVID-19 Test Receives CE Mark

Nov 9, 2021

Anavasi Diagnostics Awarded $14.9M NIH Grant for Rapid Molecular SARS-CoV-2 Test

Oct 29, 2021

Biopix-T to Launch Point-of-Care Flu Test, Plans to Raise €6M to Support Test Pipeline
Premium

May 18, 2021

Genomtec Gets CE-IVD Mark for Saliva-Based Molecular SARS-CoV-2 Test

Apr 26, 2021

Lucira Health SARS-CoV-2 Self-Test Receives Health Canada Conditional Authorization

Apr 12, 2021

Lucira Health Nabs OTC EUA for SARS-CoV-2 Test, Expects Q1 Revenues of up to $4.5M

Mar 23, 2021

FDA Grants EUAs for Direct-to-Consumer Versions of Color Coronavirus Test, Sample Collection Kit

Mar 18, 2021

Lucira Health Focuses on Consumer-Friendly Approach to Home Infectious Disease Testing
Premium

Mar 18, 2021

MicrosensDx Nabs CE Mark for Rapid SARS-CoV-2 LAMP Test

Feb 5, 2021

At-Home Infectious Disease Test Developer Lucira Health Goes Public at $17 Per Share

Feb 4, 2021

Explosive Detection Device Manufacturer DetectaChem Pivots to SARS-CoV-2 Testing
Premium

Feb 3, 2021

Stanford Team Developing Low-Cost, At-Home, Molecular COVID-19 Saliva Test
Premium

Jan 15, 2021

Jonathan Rothberg-Led Startup Looks to Bring Disposable POC SARS-CoV-2 Test to Market
Premium

Dec 28, 2020

COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020